Literature DB >> 30122557

CXCL14, a Brown Adipokine that Mediates Brown-Fat-to-Macrophage Communication in Thermogenic Adaptation.

Rubén Cereijo1, Aleix Gavaldà-Navarro1, Montserrat Cairó1, Tania Quesada-López1, Joan Villarroya2, Samantha Morón-Ros3, David Sánchez-Infantes4, Marion Peyrou1, Roser Iglesias1, Teresa Mampel1, Jean-Valery Turatsinze5, Décio L Eizirik5, Marta Giralt6, Francesc Villarroya7.   

Abstract

The beneficial effects of brown adipose tissue (BAT) are attributed to its capacity to oxidize metabolites and produce heat, but recent data suggest that secretory properties of BAT may also be involved. Here, we identify the chemokine CXCL14 (C-X-C motif chemokine ligand-14) as a novel regulatory factor secreted by BAT in response to thermogenic activation. We found that the CXCL14 released by brown adipocytes recruited alternatively activated (M2) macrophages. Cxcl14-null mice exposed to cold showed impaired BAT activity and low recruitment of macrophages, mainly of the M2 phenotype, into BAT. CXCL14 promoted the browning of white fat and ameliorated glucose/insulin homeostasis in high-fat-diet-induced obese mice. Impairment of type 2 cytokine signaling, as seen in Stat6-null mice, blunts the action of CXCL14, promoting adipose tissue browning. We propose that active BAT is a source of CXCL14, which concertedly promotes adaptive thermogenesis via M2 macrophage recruitment, BAT activation, and the browning of white fat.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  beige adipose tissue; brown adipokine; brown adipose tissue; chemokine; macrophage; thermogenesis

Mesh:

Substances:

Year:  2018        PMID: 30122557     DOI: 10.1016/j.cmet.2018.07.015

Source DB:  PubMed          Journal:  Cell Metab        ISSN: 1550-4131            Impact factor:   27.287


  64 in total

Review 1.  ComBATing aging-does increased brown adipose tissue activity confer longevity?

Authors:  Justin Darcy; Yu-Hua Tseng
Journal:  Geroscience       Date:  2019-06-22       Impact factor: 7.713

Review 2.  Obesity, Hypertension, and Cardiac Dysfunction: Novel Roles of Immunometabolism in Macrophage Activation and Inflammation.

Authors:  Alan J Mouton; Xuan Li; Michael E Hall; John E Hall
Journal:  Circ Res       Date:  2020-03-12       Impact factor: 17.367

3.  Beneficial Metabolic Effects of Mirabegron In Vitro and in High-Fat Diet-Induced Obese Mice.

Authors:  Lei Hao; Sheyenne Scott; Mehrnaz Abbasi; Yujiao Zu; Md Shahjalal Hossain Khan; Yang Yang; Dayong Wu; Ling Zhao; Shu Wang
Journal:  J Pharmacol Exp Ther       Date:  2019-04-02       Impact factor: 4.030

4.  Neural progenitor cells mediated by H2A.Z.2 regulate microglial development via Cxcl14 in the embryonic brain.

Authors:  Zhongqiu Li; Yanxin Li; Jianwei Jiao
Journal:  Proc Natl Acad Sci U S A       Date:  2019-11-11       Impact factor: 11.205

Review 5.  Inflammation and Immunity: From an Adipocyte's Perspective.

Authors:  Calvin C Chan; Michelle S M A Damen; Pablo C Alarcon; Joan Sanchez-Gurmaches; Senad Divanovic
Journal:  J Interferon Cytokine Res       Date:  2019-03-28       Impact factor: 2.607

Review 6.  The endocrine function of adipose tissues in health and cardiometabolic disease.

Authors:  Ludger Scheja; Joerg Heeren
Journal:  Nat Rev Endocrinol       Date:  2019-07-11       Impact factor: 43.330

Review 7.  Obesity: a neuroimmunometabolic perspective.

Authors:  Chelsea M Larabee; Oliver C Neely; Ana I Domingos
Journal:  Nat Rev Endocrinol       Date:  2019-11-27       Impact factor: 43.330

Review 8.  A new perspective on mesenchymal-immune interactions in adipose tissue.

Authors:  Monica T Jimenez; Michaël F Michieletto; Jorge Henao-Mejia
Journal:  Trends Immunol       Date:  2021-04-10       Impact factor: 16.687

Review 9.  The cellular and functional complexity of thermogenic fat.

Authors:  Paul Cohen; Shingo Kajimura
Journal:  Nat Rev Mol Cell Biol       Date:  2021-03-23       Impact factor: 94.444

Review 10.  The endocrine role of brown adipose tissue: An update on actors and actions.

Authors:  Aleix Gavaldà-Navarro; Joan Villarroya; Rubén Cereijo; Marta Giralt; Francesc Villarroya
Journal:  Rev Endocr Metab Disord       Date:  2021-03-12       Impact factor: 6.514

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.